Digital Psychotherapeutics Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Digital Psychotherapeutics Market size was valued at around USD 1.2 billion in 2022 and is estimated to account over USD 16.9 billion by 2032. The prevalence of psychological disorders such as depression, anxiety, and stress-related ailments is rising globally. The increased prevalence of psychological disorders is boosting the demand for accessible and effective treatment choices, thus, fueling the expansion of digital psychotherapeutics.
For instance, according to Australian Bureau of Statistics, in 2022, 21.5% of people had a 12-month mental disorder, with anxiety being the most common group (17.2% of people aged 16–85 years). In addition, according to World Health Organisation (WHO) fact sheet 2022, 1 out of every 8 individuals in this world suffers from a psychological disorder. Moreover, growing awareness of mental health concerns has reduced stigma and increased individuals' willingness to seek treatment. Individuals are becoming more self-aware of their mental health, that has substantially increased the demand for digital psychotherapeutics.
Digital psychotherapeutics are evidence-based therapy treatments and services given through digital technology and software applications. These treatments are intended to test, cure, or aid people suffering from a variety of psychological conditions, such as depression, anxiety, stress, and mood disorders.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Digital Psychotherapeutics Market size in 2022: | USD 1.2 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 29.4 |
2023 Value Projection: | USD 16.9 Billion |
Historical Data for: | 2018 to 2022 |
No of Pages: | 160 |
Tables, Charts & Figures: | 264 |
Segments Covered: | |
Growth Drivers: |
|
Pitfalls Challenges: |
|
The COVID-19 pandemic had a positive impact on the digital psychotherapeutics market. Due to reasons such as social isolation, economic uncertainty, and fear of the virus, the pandemic raised stress, anxiety, depression, and other mental health concerns. This spike in demand for mental health treatments resulted in a higher dependence on digital psychotherapeutics. Furthermore, the pandemic has pushed the use of remote patient monitoring and data analytics in mental health treatment. To deliver more personalised and effective therapies, digital platforms began to gather and analyse patient data.
The market is experiencing several notable trends that are shaping its growth and development. Factors such as increase in adoption of teletherapy, growing demand for mental health apps, and virtual reality (VR) therapy.
The market by solution is categorized into monotherapy and combination therapy. The combination therapy segment garnered USD 836 million revenue in 2022.
Based on application, the digital psychotherapeutics market is segmented into prevention, management, and treatment. The treatment segment accounted for over 58.2% market share in 2022 and is anticipated to witness fastest growth during the forecast period.
Based on indication, the digital psychotherapeutics market is segmented into phobias and anxiety disorders, psychotic disorders, and other indications. The phobias and anxiety disorders segment accounted for over 42% market share in 2022.
The digital psychotherapeutics market by business model is categorized into direct-to-patients/consumers, and Business-to-Business (B2B). The direct-to-patients/consumers segment accounted for around USD 893 million revenue size in 2022.
North America digital psychotherapeutics market accounted for USD 700.3 million revenue in 2022 and is predicted to witness substantial market growth over the analysis timeline.
The digital psychotherapeutics industry is fragmented in nature, with a large number of small and medium-sized companies competing with each other. However, there are a few larger companies that are focusing on improving their market share. Prominent players such as Pear Therapeutics, SilverCloud Health, and Woebot Health hold a notable share in the market. These companies are diligently directing their efforts towards continuous solution innovation to gain substantial market share.
Some of the eminent market participants operating in the digital psychotherapeutics industry include:
By Solution, 2018-2032 (USD Million)
By Application, 2018-2032 (USD Million)
By Indication, 2018-2032 (USD Million)
By Business model, 2018-2032 (USD Million)
The above information is provided for the following regions and countries:
The competitive landscape of the digital psychotherapeutics industry includes prominent firms, such as Novartis AG, Pear Therapeutics, SilverCloud Health, Woebot Health, Starling Minds, SwissDT, AbleTo, Inc., Spring Care, Inc, Meru, and Ginger.
The combination therapy segment generated USD 836 million in 2022 and is estimated to witness high demand through 2032 attributed to its improved treatment efficacy.
North America digital psychotherapeutics industry amassed USD 700.3 million in revenue in 2022 and is set to witness robust growth through 2032 with the increasing mental health awareness and the growing recognition of the importance of mental well-being in the region.
Digital psychotherapeutics industry reached around USD 1.2 billion in revenue in 2022 and is projected to be worth USD 16.9 billion by 2032 owing to the rising prevalence of psychological disorders and the surging demand for accessible and effective treatment choices.